home / stock / vm:cc / vm:cc news

VM:CC News and Press, Voyageur Pharmaceuticals Ltd.

Stock Information
Company Name: Voyageur Pharmaceuticals Ltd.
Stock Symbol: VM:CC
Market: TSXVC
Website: voyageurpharmaceuticals.ca
Menu
VM:CC VM:CC Quote VM:CC Short VM:CC News VM:CC Articles VM:CC Message Board
Get VM:CC Alerts

News, Short Squeeze, Breakout and More Instantly...
VM:CC - Voyageur Pharmaceuticals Grants Deferred Share Units

(TheNewswire) Calgary, Canada – TheNewswire - July 9, 2024 - Voyageur Pharmaceuticals Ltd . ( TSX.V: VM ) ( OTC : VYYRF) ("Voyageur" or the "Corporation") , a provider of innovative medical imaging solutions, announces that it has issued 435,925 De...
VM:CC - Voyageur Pharmaceuticals and Rain Cage Carbon Partner to Develop Advanced Radiology Contrast Agents

--News Direct-- Voyageur Pharmaceuticals CEO Brent Willis joined Steve Darling from Proactive to announce that the company and Rain Cage Carbon are advancing their collaboration following the first commercial creation of a V@C60 endohedral fullerene or Vanadium atom inside a C60 molecule....

VM:CC - Testing to Begin of Radiology Endohedral Fullerenes, a Milestone in Nanotechnology & Drug Development

(TheNewswire) Calgary, Alberta, Canada, June 11, 2024 – TheNewswire – Voyageur Pharmaceuticals Ltd . (TSX.V: VM) (USA: VYYRF) ("Voyageur" or the "Company") announces that in an innovative endeavor, Voyageur and Rain Cage Carbon Inc. ("Rain Cage") are fo...

VM:CC - Voyageur Pharmaceuticals Secures $1.9 Million Sales Contract for Latin America

--News Direct-- Voyageur Pharmaceuticals CEO Brent Willis joined Steve Darling from Proactive to announce a significant milestone for the company with the signing of its first sales contract valued at USD $1.9 million. The contract spans a three-year term and involves a distribution partn...
VM:CC - Voyageur Pharmaceuticals Ltd Secures USD $1.9 Million Sales Contract for SmoothX 2% Barium Contrast

(TheNewswire) Calgary, Canada, May 28, 2024 – TheNewswire – Voyageur Pharmaceuticals Ltd . (TSX.V: VM) (USA: VYYRF) ("Voyageur" or the "Company") proudly announces its first international distribution agreement with a sales commitment of USD $1.9 million ( ...

VM:CC - Voyageur Pharmaceuticals Ltd Grants Deferred Share Units Compensation to Independent Directors

(TheNewswire) Calgary, Canada – The Newswire – April 2, 2024- Voyageur Pharmaceuticals Ltd (TSXV:VM) (OTC: VYYRF) ("Voyageur" or the "Corporation"), a provider of innovative medical imaging solutions, on April 2, 2024, announces it issued 1,020,055 Deferred Share Units...

VM:CC - Voyageur Pharmaceuticals Files Audited Annual Financial Statements and Grants Stock Options

(TheNewswire) Calgary, Alberta, Canada / TheNewswire / March 26, 2024 - Voyageur Pharmaceuticals Ltd . ( TSX.V: VM ) (USA: VYYRF) (" Voyageur " or the " Company "), announces that it has filed its annual audited financial statements and management's d...
VM:CC - Voyageur Achieves Milestone with Rain Cage Royalty Agreement for Sustainable Carbon Drug Development

(TheNewswire) Calgary, Alberta, Canada – TheNewswire - March 13, 2024 - Voyageur Pharmaceuticals Ltd . ( TSX.V: VM ) (USA: VYYRF) ("Voyageur" or the "Corporation"), announces a significant advancement in its partnership with Rain Cage Carbon Inc. ("Rain Cage")...

VM:CC - Voyageur Pharmaceuticals and API Forge Alliance for Carbon-Based Imaging Drug Advancement

(TheNewswire) Calgary, Canada – TheNewswire - March 4, 2024 - Voyageur Pharmaceuticals Ltd . (TSX.V: VM) (USA: VYYRF) ("Voyageur" or the "Corporation") and Applied Pharmaceutical Innovation (API), a leading industry-funded not-for-profit organization driving l...

VM:CC - Voyageur Pharmaceuticals Ltd. Announces Closing of Private Placement

(TheNewswire) Calgary, Canada / TheNewswire / March 1, 2024 - Voyageur Pharmaceuticals Ltd . ( TSX.V:VM ) (USA:VYYRF) ("Voyageur" or the "Company"), a provider of innovative medical imaging solutions, is pleased to announce it has closed its previously announced (Jan...
Next 10